Galectin Therapeutics Inc SEC filings GALT
Galectin Therapeutics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Oct 18, 2011. Its latest annual report, Form ARS, was filed on Oct 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 13, 2026 | — |
| DEF 14A | Proxy statement | Oct 13, 2026 | Dec 3, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 2, 2026 | Dec 3, 2026 |
| DEFA14A | Additional proxy material | Oct 22, 2025 | — |
| DEF 14A | Proxy statement | Oct 22, 2025 | Dec 3, 2025 |
| DEFA14A | Additional proxy material | Dec 3, 2024 | — |
| DEF 14A | Proxy statement | Dec 3, 2024 | Jan 23, 2025 |
| DEFA14A | Additional proxy material | Oct 6, 2023 | — |
| DEF 14A | Proxy statement | Oct 6, 2023 | Dec 7, 2023 |
| DEFA14A | Additional proxy material | Oct 17, 2022 | — |
| DEF 14A | Proxy statement | Oct 17, 2022 | Dec 1, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 6, 2022 | Dec 1, 2022 |
| DEF 14A | Proxy statement | Oct 12, 2021 | Dec 3, 2021 |
| PRE 14A | Preliminary proxy statement | Sep 22, 2021 | Dec 3, 2021 |
| DEF 14A | Proxy statement | Oct 19, 2020 | Dec 3, 2020 |
| DEF 14A | Proxy statement | Oct 17, 2019 | Dec 4, 2019 |
| DEF 14A | Proxy statement | Apr 11, 2018 | May 22, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2018 | May 22, 2018 |
| DEF 14A | Proxy statement | Nov 7, 2017 | Dec 14, 2017 |
| PRE 14A | Preliminary proxy statement | Oct 20, 2017 | Dec 14, 2017 |
| DEF 14A | Proxy statement | Nov 10, 2016 | Dec 15, 2016 |
| DEF 14A | Proxy statement | Apr 8, 2015 | May 21, 2015 |
| DEF 14A | Proxy statement | Mar 21, 2014 | May 14, 2014 |
| DEF 14A | Proxy statement | Apr 12, 2013 | May 23, 2013 |
| DEF 14A | Proxy statement | Apr 20, 2012 | May 24, 2012 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GALT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Norcross, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1133416
- Former names
- PRO PHARMACEUTICALS INC (until May 26, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.